Brammer Bio Establishes Dedicated Late Phase Development and Commercial Manufacturing Facility for Advanced Cell and GeneTherapies in Lexington, Mass.

Brammer Bio Establishes Dedicated Late Phase Development and Commercial Manufacturing Facility for Advanced Cell and GeneTherapies in Lexington, Mass.

Download Press Release

Brammer Bio, the best-in-class cell and gene therapy contract development and manufacturing organization, is proud to announce plans to build-out a 50,000 sq. ft. facility dedicated to late phase development, including Phase III and commercial production of viral vector-based and cell-based advanced therapies. The facility will be qualified and operational by Q2 of 2017.

Read More

Brammer Bio Formed Through Merger of Brammer Bio pharmaceuticals and Florida Biologix

Brammer Bio Formed Through  Merger of  Brammer Bio pharmaceuticals  and Florida Biologix

Download Press Release

Brammer Bio is a best-in-class cell and gene therapy biologics contract development and manufacturing organization (CDMO).

The merger will combine deep technical expertise with demonstrated capabilities and operating approaches and the quality standards required for commercial manufacturing.

Brammer Bio is focused on providing process development, clinical, and commercial supply of autologous and allogeneic cell therapy, ex vivo gene therapy and viral vector products enabling the delivery of novel medicines and improving patient health.

Read More